TRENTON, N.J. (AP) - Shares of beleaguered Canadian drugmaker Valeant Pharmaceuticals plunged again Monday after its CEO was subpoenaed by a congressional committee.
The Senate Aging Committee said in a statement that J. Michael Pearson, Valeant's CEO since September 2010, is among the witnesses expected to testify on April 27.
...